Table 2.
Objective response rates at 2, 6 and 12 for PM.
| Time Point (Evaluable Lesion) | CR (%) | PR (%) | SD (%) | PD (%) | Focal Control Rate (%) | N/E |
|---|---|---|---|---|---|---|
| 2-months (n = 21) | 33.3 | 14.3 | 42.9 | 9.5 | 90.5 | 0 |
| 6-months (n = 19) | 26.3 | 31.6 | 26.3 | 15.8 | 84.2 | 9.5 |
| 12-months (n = 15) | 40 | 33.3 | 0 | 26.7 | 73.3 | 28.6 |
PM: pancreatic metastasis CR: complete response, PR: partial response, SD: stable disease PD: progression disease; N/E Not evaluable lesion (that have progressed or follow up is < to the evaluation time point); Focal Control R ate = CR + PR + SD.